You searched for "Urinary"
Essential Urology: A Guide to Clinical Practice (2nd Edition)
Essential Urology: A Guide to Clinical Practice is an easy read from cover to cover; on average it will take three to four days to finish reading. However, it is packed with information presented in a very succinct manner. The...
Male LUTS: where do we stand?
Patients’ preferences and expectations depend on cultural, geographical, economic and national factors. Data from different countries should be interpreted with caution when applied to the individual patient. Patients rarely seek help for benign prostatic obstruction (BPO) unless urinary retention occurs,...
Urological in-flight medical events
The future of air travel may seem uncertain at the present time, but up until the COVID-19 pandemic, approximately 44,000 inflight medical emergencies occurred annually, averaging 1 in 604 flights. Some of you will have heard the heart-sink announcement “if...
Trade-offs between risks and benefits of localised prostate cancer treatments – the COMPARE study
We know little about the trade-offs men make when considering the oncological and functional outcomes of individual treatment options for localised prostate cancer, and decisions are often influenced by physician opinion. The likely compromised functional results are viewed as a...
Multidisciplinary consensus on the classification of prenatal and postnatal UT dilation classification system
There is a lack of evidence in the literature correlating prenatal and postnatal urinary tract (UT) dilation pathology because classification systems vary, differing descriptive terms are used, and because dilation is a dynamic process and uropathies present a spectrum of...
The role of continuous prophylactic antibiotics following JJ stent insertion
Urinary tract infections (UTI) and stent-related symptoms (SRS) are frequently recognised complications of ureteric stent placement. Antibiotic administration at induction prior to ureteric stent insertion is recommended by the European Association of Urology (EAU). Commencing prophylactic antibiotics for the ‘entire...
Adults with myelomeningocoele: life situation and bladder and bowel management
Long-term outcome studies of patients to include what happens at transition to adulthood are rare but increasing in the literature as paediatric urologists are questioning their long-term results more deeply. These authors aimed to assess life situation and bladder and...
Is silodosin the new first-line treatment for LUTS secondary to BPH?
This meta-analysis aims to evaluate the safety profile and non-inferiority of silodosin when compared to tamsulosin for the treatment of male lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH). As the prostate and bladder neck are abound...Metabolic screening and stone-prevention in urolithiasis patients
The incidence and prevalence of kidney stones is increasing [1,2]. Significant recurrence rates are noted with 14% of patients experiencing a further episode at one year, 35% at five years, and 52% at 10 years [3]. Over 10% of stone...
Intravesical cytosine arabinoside + Mitomycin C for bladder cancer – is it beneficial?
Mitomycin C (MMC) is often used as an intravesical therapy for low / intermediate risk non-muscle invasive bladder cancer. This randomised controlled trial (RCT) was designed to assess the safety and efficacy of MMC + cytosine arabinoside (Ara-C). Ara-C was...
PDE5I in LUTS – how do they work – no proof yet
Phosphodiesterase type 5 (PDE5) inhibitors used in erectile dysfunction (ED) have been shown to improve lower urinary tract symptoms (LUTS) as well. The mechanism is not well understood. One of the hypotheses for benign prostatic hyperplasia (BPH) – LUTS is...
